Equities research analysts predict that UnitedHealth Group Inc (NYSE:UNH) will report sales of $54.85 billion for the current quarter, Zacks reports. Six analysts have made estimates for UnitedHealth Group’s earnings, with the lowest sales estimate coming in at $54.15 billion and the highest estimate coming in at $55.38 billion. UnitedHealth Group posted sales of $48.72 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 12.6%. The company is expected to announce its next quarterly earnings results on Tuesday, April 17th.

According to Zacks, analysts expect that UnitedHealth Group will report full year sales of $54.85 billion for the current year, with estimates ranging from $223.50 billion to $225.72 billion. For the next fiscal year, analysts anticipate that the company will post sales of $242.70 billion per share, with estimates ranging from $240.11 billion to $245.44 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that follow UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the previous year, the firm posted $2.11 EPS. The company’s quarterly revenue was up 9.5% compared to the same quarter last year.

Several research analysts recently issued reports on the company. Deutsche Bank lifted their price objective on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Citigroup boosted their price target on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a report on Wednesday, October 18th. Finally, BMO Capital Markets began coverage on UnitedHealth Group in a report on Monday, October 16th. They issued an “outperform” rating and a $250.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $243.22.

In other news, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Michele J. Hooper sold 5,000 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,655 shares of company stock valued at $7,469,083. Insiders own 0.89% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in UNH. Iberiabank Corp boosted its position in UnitedHealth Group by 3.0% during the 2nd quarter. Iberiabank Corp now owns 4,311 shares of the healthcare conglomerate’s stock worth $799,000 after purchasing an additional 127 shares during the period. Private Trust Co. NA boosted its position in UnitedHealth Group by 10.1% during the 2nd quarter. Private Trust Co. NA now owns 8,150 shares of the healthcare conglomerate’s stock worth $1,511,000 after purchasing an additional 748 shares during the period. Covenant Asset Management LLC boosted its position in UnitedHealth Group by 2.7% during the 2nd quarter. Covenant Asset Management LLC now owns 7,185 shares of the healthcare conglomerate’s stock worth $1,332,000 after purchasing an additional 190 shares during the period. ETF Portfolio Partners Inc. purchased a new stake in UnitedHealth Group during the 2nd quarter worth $206,000. Finally, Central Bank & Trust Co. boosted its position in UnitedHealth Group by 0.8% during the 2nd quarter. Central Bank & Trust Co. now owns 17,992 shares of the healthcare conglomerate’s stock worth $3,336,000 after purchasing an additional 134 shares during the period. Institutional investors and hedge funds own 86.09% of the company’s stock.

Shares of UnitedHealth Group (UNH) traded up $0.19 during trading on Thursday, hitting $243.35. The company had a trading volume of 4,289,381 shares, compared to its average volume of 3,050,000. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group has a 1 year low of $156.49 and a 1 year high of $244.35. The firm has a market cap of $235,290.00, a P/E ratio of 22.72, a P/E/G ratio of 1.42 and a beta of 0.66.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/unitedhealth-group-inc-unh-expected-to-announce-quarterly-sales-of-54-85-billion/1817265.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.